Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect Cagrilintide Weight Loss Appetite Control and Fat Burning Support Were entering a new chapter in weight and metabolic health. While GLP 1s have been in the spotlight, researchers are finding that amylin agonists may offer similar levels of weight loss and were Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug VisualAbstract: Combined cagrilintide and semaglutide for weight management well tolerated in early clinical trials 2 Minute Medicine